Exocrine Pancretic Pathology: Clinical and Molecular Updates
Dr. Pilar Navarro E-Mail
The Spanish National Research Council at the Institute of Biomedical Research of Barcelona (IIBB-CSIC); Hospital del Mar Medical Research Institute (IMIM); Institute of Biomedical Research August Pi i Sunyer (IDIBAPS); Barcelona, Spain
Research Keywords: pancreatic cancer, molecular mechanism of disease, novel molecular targets, biomarkers
Dr. Laura Visa E-Mail
Department of Medical Oncology, Hospital del Mar, 08003-Barcelona, Spain
Research Keywords: pancreatic cancer, biomarkers, biliary tract tumors
The pancreas is a complex gastroabdominal organ with both exocrine and endocrine functions. Exocrine pancreas is the vast majority of the gland (>85%) and plays a key role in digestion by secretion of digestive enzymes and bicarbonate. In this Special Issue, we will focus in exocrine pancreatic disorders, including inflammatory diseases (acute and chronic pancreatitis) and neoplasias. Among the last, we will pay special attention to pancreatic ductal adenocarcinoma, which is the most frequent type of pancreatic cancer (>90%) and is the tumor with the lowest five-year survival rate of any cancer. The information collected here will help to increase our knowledge on the pathophysiology of exocrine pancreatic diseases, thus hoping to contribute to find better strategies for the management of all these relevant clinical disorders.
This Special Issue, entitled “ Exocrine Pancreatic Pathology: clinical and molecular updates” welcomes original articles, reviews and communications/opinion related to the above-mentioned topics.
Keywords: Pancreatic cancer, chronic pancreatitis, acute pancreatitis, biliary tract tumors, biomarkers, diagnosis, therapy